Cuorips Inc

TSE • Healthcare • Biotechnology • Quote as of 10/30/2026

Company Profile

IndustryBiotechnology

SectorHealthcare

ExchangeTSE

Market Capitalization65,256 mln

Float6.22 mln

Earnings Date11/13/2026

Piotroski F-Score

2 / 9

Weak

Beneish M-Score

-2.22

Caution advised

Relative Strength

99 / 100

Top performer

Pre-Tax Margin

-893%

Severely loss-making

ROE

-22.93

Deeply negative

Altman Z-Score

96.53

Exceptional

Business Description

Cuorips Inc. is a Tokyo-based company founded in 2017 that develops and sells heart muscle tissue grown from human stem cells. The company also manufactures cell-based products and offers contract development, manufacturing, and consulting services to clients in the life sciences field.

Key Fundamentals

EPS-138

ROE-22.93

RPS15.53

ROIC-96.53

ROA-21.62

EBITDA, mln-1,052

EV / EBITDA-51.63

EV / EBIT-47.31

Revenue, mln129

EV / Revenue422

Quote Details

Last 7,060.00

Change -290 (-3.95%)

Open 7,320.00

Volume 223,700

Turnover 1,579,321,984

Average Volume 213,924

Financial Ratios

Pre-Tax Profit Margin-893

Leverage Ratio1.08

Current Ratio16.26

Price / Book13.59

Price / Tangible Book13.96

Price / Sales467

Financial Strength

Altman Z-Score96.53

Piotroski F-Score 2 / 9

Beneish M-Score-2.22

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	9.29%	98 / 100
1 Month	6.33%	92 / 100
2 Months	51.66%	98 / 100
6 Months	0.14%	49 / 100
1 Year	5.69%	48 / 100